Patch Testing in Systemic Drug Eruptions

2020 ◽  
pp. 97-109
Author(s):  
Derk P. Bruynzeel ◽  
Howard I. Maibach
1997 ◽  
Vol 15 (4) ◽  
pp. 479-484 ◽  
Author(s):  
Derk P. Bruynzeel ◽  
Howard I. Maibach

2009 ◽  
Vol 23 (10) ◽  
pp. 677-683 ◽  
Author(s):  
Nisha Mistry ◽  
Jonathan Shapero ◽  
Richard I Crawford

Drug-induced cutaneous eruptions are named among the most common side effects of many medications. Thus, cutaneous drug eruptions are a common cause of morbidity and mortality, especially in hospital settings. The present article reviews different presentations of drug-induced cutaneous eruptions, with a focus on eruptions reported secondary to the use of interferon and ribavirin. Presentations include injection site reactions, psoriasis, eczematous drug reactions, alopecia, sarcoidosis, lupus, fixed drug eruptions, pigmentary changes and lichenoid eruptions. Also reviewed are findings regarding life-threatening systemic drug reactions.


Dermatitis ◽  
2011 ◽  
Vol 22 (2) ◽  
pp. 114-118 ◽  
Author(s):  
Justin O. Endo ◽  
Crystal Davis ◽  
Douglas L. Powell

2008 ◽  
Vol 4 (2) ◽  
pp. 66 ◽  
Author(s):  
Antonino Romano ◽  
Marinella Viola ◽  
Francesco Gaeta ◽  
Gabriele Rumi ◽  
Michela Maggioletti
Keyword(s):  

2004 ◽  
Vol 50 (4) ◽  
pp. 259-261 ◽  
Author(s):  
Naga Prasad Grandhe ◽  
Inderjeet Kaur ◽  
Davinder Parsad ◽  
Sunil Dogra

2008 ◽  
Vol 50 (3) ◽  
pp. 156-156 ◽  
Author(s):  
Ricardo Vieira ◽  
M Gonçalo ◽  
A Figueiredo
Keyword(s):  

Author(s):  
Esen Özkaya ◽  
Kurtuluş Didem Yazganoğlu
Keyword(s):  

2011 ◽  
Vol 65 (4) ◽  
pp. 195-201 ◽  
Author(s):  
Pedro Andrade ◽  
Ana Brinca ◽  
Margarida Gonçalo

Sign in / Sign up

Export Citation Format

Share Document